Rare Diseases Lure Big Drugmakers
This is a discussion on Rare Diseases Lure Big Drugmakers within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; In seeking to acquire biotechnology company Genzyme Corp, Sanofi-Aventis is hoping to gain entry into a field that has ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
08-04-2010, 01:11 PM
|
|||
|
|||
Rare Diseases Lure Big Drugmakers
In seeking to acquire biotechnology company Genzyme Corp, Sanofi-Aventis is hoping to gain entry into a field that has long been dismissed by big pharmaceutical companies: rare diseases.
Reuters Health Information More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| U.S. FDA Panel Explores Boost for Rare Drugs | industry_news | Other Clinical Pharmacy News | 0 | 06-29-2010 03:17 PM |
| Pfizer creates a new R&D unit for rare diseases | industry_news | Biotechnology News | 0 | 06-15-2010 08:44 AM |
| Bill Clinton, Drugmakers Announce Cheaper HIV Drugs | industry_news | Other Clinical Pharmacy News | 0 | 08-07-2009 03:41 PM |
| FDA Works With Drugmakers to Increase Oxycodone Production | chantell.reagan | FDA Recalls, Market Withdrawals and Safety Alerts | 0 | 04-02-2009 07:37 PM |
| Value of PAs in complex and costly diseases | participant5 | Managed Care Pharmacy Administrative Issues | 4 | 11-14-2008 10:57 AM |
© 2008 DrugManagementForum™ powered by |
 |